Hill Lab Ovarian and Endometrial Cancer Organoid and Tissue Bank:

As the Hill lab continues to generate and profile ovarian and endometrial cancer organoid cultures from new patients coming to BWH/DFCI to understand disease mechanisms and to try to determine if organoid functional assays on each patient's culture will be useful in predicting patient response, we continue to generate a large bank of tissue and organoid cultures across all epithelial ovarian and endometrial cancer subtypes and also generate organoids from benign fallopian tube, ovarian surface epithelium, and other matched normal cells.

​Please contact Dr. Hill to collaborate, sarah_hill@dfci.harvard.edu. We are excited to partner with other researchers for biologic discovery, therapeutic discovery, new functional assay development, and biomarker development using our organoid cultures.